Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Myeloid 2 Sarcoma 1 Plasma cell 1 Lymphoid 1 Gastrointestinal 1 Breast 1

Conditions

Cholangiocarcinoma 1

Interventions

Oxaliplatin 1413 Fluorouracil 1301 Capecitabine 1088 Gemcitabine 1046 Leucovorin 932 Irinotecan 818 Bevacizumab 804 Cisplatin 671 Radiotherapy 536 Cetuximab 470 pembrolizumab 430 Paclitaxel 390 Nivolumab 337 130-nm albumin-bound paclitaxel 325 Drug Therapy 314 Docetaxel 287 S 1 (combination) 275 Sorafenib 266 Folfox protocol 261 Albumin-Bound Paclitaxel 259 sintilimab 211 durvalumab 210 Surgical Procedures, Operative 204 tislelizumab 203 Radiosurgery 202 lenvatinib 201 apatinib 200 Carboplatin 188 Magnetic Resonance Spectroscopy 183 regorafenib 181

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Association × Gastrointestinal × Clear all

NCT01912053 2018-05-11

MispheC

Center Eugene Marquis

Phase 2 Completed

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡